Telehealth Ledger
Embody logoProvider treatment guide · checked 21 October 2026

Embody Tirzepatide

Published by Telehealth LedgerSource checked 21 October 2026

Embody lists Compounded tirzepatide injection at $349 regular price; one-month sale $129. Medication is included in that catalog price. Readers comparing Embody's compounded tirzepatide program with other tirzepatide offers and who need a treatment-specific, not provider-generic, starting point. The commercial terms were checked 21 October 2026; state access, clinician approval, dispensing details, and personal suitability remain separate questions.

We may earn a commission if you start a program through links on this page. It doesn't change prices or how we sort them. Disclosure

Visit Embody Affiliate link · we may earn a commissionRead the full review
Embody Tirzepatide treatment illustration
$349regular price; one-month sale $129
Includedmedication in published price
Weekly subcutaneous injectionlisted format
21 October 2026commercial terms checked
1 listed restrictionpublished state availability

The short answer for this provider-treatment pair: Embody Tirzepatide

Resolve whether Embody's compounded tirzepatide listing is the relevant program to compare, with its route and current catalog terms distinguished from Embody's compounded semaglutide offer.

Readers comparing Embody's compounded tirzepatide program with other tirzepatide offers and who need a treatment-specific, not provider-generic, starting point. A fair reading keeps Embody's Tirzepatide listing separate from adjacent products that may use a related medication or sit in the same provider catalog.

Do not blur this product with adjacent options: Compounded tirzepatide injection

Compounded tirzepatide injection is listed as a compounded product in Weekly subcutaneous injection format. FDA states that compounded drugs are not FDA-approved and do not receive the same premarket review as approved drug products. Ask for the exact formulation and dispensing pharmacy before purchase. That status is central to this Embody guide because a related medication name does not make branded, compounded, oral, nasal, and injectable products interchangeable.

Embody lists Compounded tirzepatide injection in Weekly subcutaneous injection format. The Compounded tirzepatide injection comparison groups offers with the same treatment and route so their prices can be assessed fairly. A shared medication name does not make different formulations interchangeable. This guide does not provide dose instructions or route conversions, and it does not establish that another formulation has the same evidence, safety profile, convenience or outcomes.

The published price and its terms: Embody

Embody lists Compounded tirzepatide injection at $349 regular price; one-month sale $129, checked 21 October 2026. Read the amount together with the billing interval and any promotion or prepayment shown beside it. A lower monthly equivalent may require a longer commitment and a larger charge today. The linked price source is dated evidence of the advertised offer, not an independently verified checkout total or a guarantee that every dose and plan costs the same.

The published price includes medication. It does not verify that labs, every consultation, supplies, expedited shipping, or future dose changes are included unless the source says so. Those items remain checkout questions. For Embody Tirzepatide, read medication inclusion as one part of the offer, not as proof that every service surrounding the prescription is free. The dated source establishes the advertised basis; it does not independently audit the final checkout, dispensing event, or quality of care.

Billing terms to settle before payment: Embody Tirzepatide

The published offer lists $349 regular price; one-month sale $129. It does not establish every possible dose, renewal, refund, or future price. Confirm the complete checkout total and next billing date before payment. For Embody's Tirzepatide offer, distinguish the introductory charge, continuing charge, upfront payment and required commitment. A monthly equivalent can be useful, but only when the required payment and term remain visible beside it.

The Embody price source for this offer was checked on 21 October 2026. Before paying for Tirzepatide, compare the amount charged today with the amount charged later, the number of months purchased, the renewal date, the cancellation window, and the refund boundary after clinical or pharmacy processing. A published price cannot safely answer those policy questions unless the cited provider evidence does.

Coverage, eligibility, and fulfillment: Tirzepatide

Published availability lists Louisiana as restricted for weight-loss programs. That list reflects the sources checked on the date shown; it does not prove eligibility everywhere else. Confirm the current state rule before intake. The Tirzepatide access check belongs near the price because a low published figure has little decision value when Embody cannot serve the reader's state or the selected product cannot be fulfilled there.

For Embody Tirzepatide, the consumer brand, administrative platform, clinical group, and dispensing pharmacy can be different entities. A provider page may describe a national service while licensure, product rules, and pharmacy coverage narrow actual fulfillment. Ask which clinician entity would review the intake and which licensed pharmacy would dispense this exact product in the reader's state before treating access as settled.

Who provides care and fulfills the order: Embody

The linked sources identify Modern Metabolic Medicine, Inc. as Embody's administrator. Administrative operator named in the terms. These entities can perform different jobs, so the consumer-facing brand should not automatically be described as the clinician or dispensing pharmacy for Tirzepatide.

Shipping: Medication, supplies, and standard shipping are included in the published GLP-1 totals. An unresolved issue for Embody's Tirzepatide offer remains: Sale price is not the continuing price: Checked 17 October 2026, the one-month product pages label a sale price and a regular price and publish no selling plan. The sale is not recorded as a continuing price. Rankings use the regular price. Ask the provider how that issue affects the selected order. A published price does not resolve uncertainty about billing, fulfillment, eligibility or the terms that apply after payment.

Compare prices across providers: Tirzepatide

The linked Tirzepatide comparison places Embody beside other providers with published prices. Check the same details for every offer: continuing price, introductory period, required prepayment, medication inclusion, product type, delivery format, verification date, and state evidence. If two offers use different routes or one price excludes medication, a simple lowest-number verdict would not be a like-for-like conclusion.

Use the comparison link to check other Tirzepatide offers, then open Embody's site to confirm the selected product. A provider may list several related treatments or plan lengths on the same page. Make sure the intake and checkout still name Compounded tirzepatide injection, use the weekly subcutaneous injection format, and show the same medication inclusion and billing basis before treating the two offers as equivalent.

When this offer belongs on the shortlist: Embody Tirzepatide

Embody's listing answers the basic commercial question for Tirzepatide, but it cannot answer personal eligibility, medical fit, pharmacy assignment, or an individual outcome. Those limits belong in the decision, not in fine print after it.

Readers comparing Embody's compounded tirzepatide program with other tirzepatide offers and who need a treatment-specific, not provider-generic, starting point. Treat the provider link as a verification step: confirm the product name, price phase, medication inclusion, state rule, pharmacy, renewal date, and refund boundary before payment.

Common questions

Embody Tirzepatide FAQ

What is the price for this treatment for Embody Tirzepatide?
The linked price source lists $349 regular price; one-month sale $129 for Compounded tirzepatide injection, checked 21 October 2026. The amount should be read with any introduction, prepayment, or commitment shown in the same offer record. It is a dated published commercial fact, not a promise that every checkout configuration, future renewal, or product change will cost the same amount.
Is medication part of that number in the Embody figure?
The published Embody offer includes medication for Tirzepatide. That does not establish that the price includes labs, every consultation, supplies, faster shipping, dose-related price changes, or a future refill. Confirm those items and the complete charge in the selected checkout before treating the figure as all-inclusive.
Do these details apply to other formats for Embody Tirzepatide?
This guide covers Compounded tirzepatide injection in Weekly subcutaneous injection format. It does not transfer price, regulatory status, evidence, convenience, dosing, pharmacy, or fulfillment claims to another Tirzepatide formulation or to a related product. Compare route and product identity before comparing the price because similar medication names can still describe materially different offers.
Does missing state information mean nationwide service for Embody Tirzepatide?
Published availability lists Louisiana as restricted for this type of treatment. Confirm eligibility directly because provider coverage can change. A published state list is only one part of eligibility. Embody must also confirm clinician licensure, product eligibility, and pharmacy fulfillment for the specific Tirzepatide prescription. Completing an intake does not guarantee approval, dispensing, or a particular outcome.
Which page ranks alternatives for Embody Tirzepatide?
Use the Tirzepatide comparison to check the dated prices, product formats and plan terms across providers. Compare Embody only with offers that disclose the same price components, medication inclusion, commitment, and format; otherwise explain why the rows are not directly equivalent.

Sources and method

Telehealth Ledger checked provider pages, plan terms, and independent context on 21 October 2026. This page compares published commercial terms. It is not a rating, medical advice, or a guarantee that a clinician will prescribe treatment.